Age: 68 Director since: 2025 INDEPENDENT Key skills: Public Company Board Healthcare Technology Recent Experience: Harvard Medical School Sidney Farber Professor of Medicine (2018-present) Professor of Medicine (2002-2018) Dana-Farber Cancer Institute Professor (2002-present) Howard Hughes Medical Institute Investigator (2002-present) Assistant Investigator (1998-2002) U.S. public company directorships: Eli Lilly and Company (Directors and Corporate Governance Committee, Science and Technology Committee (Chair)) Other highlights: Recipient of numerous noteworthy scientific awards, including: Nobel Prize in Physiology or Medicine Albert Lasker Basic Medical Research Award Canada Gairdner International Award Wiley Prize in Biomedical Sciences from the Rockefeller University Paul Marks Prize for Cancer Research from the Memorial Sloan Kettering Cancer Center Education: Doctorate in Medicine, Duke University School of Medicine Bachelor of Arts in Mathematics, Duke University Associate Bachelor in Chemistry, Duke University Reason for Nomination: Dr. Kaelin is a Nobel Laureate, scientist, academician, and physician who provides valuable leadership and decades of experience in medical research and discovery, particularly in oncology.